Mathias Lidgren

822 total citations
12 papers, 442 citations indexed

About

Mathias Lidgren is a scholar working on Economics and Econometrics, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathias Lidgren has authored 12 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathias Lidgren's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Breast Cancer Treatment Studies (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Mathias Lidgren is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Breast Cancer Treatment Studies (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Mathias Lidgren collaborates with scholars based in Sweden, Germany and Switzerland. Mathias Lidgren's co-authors include Bengt Jönsson, Nils Wilking, Clas Rehnberg, Jonas Bergh, A. Gerson Hollander, Ola Weiland, Stylianos E. Antonarakis, Jonas Lundkvist, Michel Guipponi and Robert Steinfeld and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Mathias Lidgren

12 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathias Lidgren Sweden 7 241 209 123 54 50 12 442
T. Younis Canada 11 184 0.8× 83 0.4× 100 0.8× 41 0.8× 69 1.4× 32 308
Angela K. Green United States 12 170 0.7× 93 0.4× 91 0.7× 27 0.5× 32 0.6× 23 508
E.C. Faulkner United States 9 153 0.6× 135 0.6× 76 0.6× 47 0.9× 58 1.2× 20 500
Abiola Ibraheem United States 11 140 0.6× 68 0.3× 142 1.2× 69 1.3× 51 1.0× 26 364
Joseph C. Del Paggio Canada 13 248 1.0× 384 1.8× 109 0.9× 66 1.2× 26 0.5× 28 796
Koen Degeling Australia 10 125 0.5× 104 0.5× 79 0.6× 16 0.3× 22 0.4× 35 310
Tallal Younis Canada 15 331 1.4× 77 0.4× 165 1.3× 93 1.7× 80 1.6× 34 577
Caroline S. Bennette United States 14 121 0.5× 211 1.0× 114 0.9× 13 0.2× 190 3.8× 24 561
Judith A. Veum United States 6 331 1.4× 107 0.5× 259 2.1× 35 0.6× 78 1.6× 11 605
Grant Lawless United States 13 328 1.4× 137 0.7× 52 0.4× 10 0.2× 120 2.4× 27 587

Countries citing papers authored by Mathias Lidgren

Since Specialization
Citations

This map shows the geographic impact of Mathias Lidgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Lidgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Lidgren more than expected).

Fields of papers citing papers by Mathias Lidgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Lidgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Lidgren. The network helps show where Mathias Lidgren may publish in the future.

Co-authorship network of co-authors of Mathias Lidgren

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Lidgren. A scholar is included among the top collaborators of Mathias Lidgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Lidgren. Mathias Lidgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Flygare, Johan, Karin Pike‐Overzet, Alexander B. Mohseny, et al.. (2023). Single-Cell-Multiomics Demonstrates Molecular Efficacy of a Clinical Lentiviral Vector for Gene Therapy of RPS19-Deficient Diamond-Blackfan Anemia. Blood. 142(Supplement 1). 943–943. 1 indexed citations
2.
Ranza, Emmanuelle, Werner J. Z’Graggen, Mathias Lidgren, et al.. (2020). SCN8Aheterozygous variants are associated with anoxic‐epileptic seizures. American Journal of Medical Genetics Part A. 182(5). 1209–1216. 5 indexed citations
3.
Varvagiannis, Konstantinos, Sylviane Hanquinet, Peter C. Rimensberger, et al.. (2017). Congenital Neuronal Ceroid Lipofuscinosis with a Novel CTSD Gene Mutation: A Rare Cause of Neonatal-Onset Neurodegenerative Disorder. Neuropediatrics. 49(2). 150–153. 15 indexed citations
4.
Lidgren, Mathias, Nils Wilking, Bengt Jönsson, & Clas Rehnberg. (2008). Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer. Acta Oncologica. 47(6). 1018–1028. 42 indexed citations
5.
Dranitsaris, George, Mathias Lidgren, Jonas Lundkvist, & RE Coleman. (2008). PCN56 NAB-PACLITAXEL OR DOCETAXEL; AS ALTERNATIVES TO CONVENTIONAL PACLITAXEL FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC): A COST UTILITY ANALYSIS IN FIVE EUROPEAN COUNTRIES. Value in Health. 11(3). A71–A71. 1 indexed citations
6.
Dranitsaris, George, Mathias Lidgren, Jonas Lundkvist, & Robert E. Coleman. (2008). Nab-paclitaxel or docetaxel as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): a cost utility analysis in five European countries. Journal of Clinical Oncology. 26(15_suppl). 6571–6571. 2 indexed citations
7.
Lidgren, Mathias, Nils Wilking, Bengt Jönsson, & Clas Rehnberg. (2007). Resource use and costs associated with different states of breast cancer. International Journal of Technology Assessment in Health Care. 23(2). 223–231. 55 indexed citations
8.
Lidgren, Mathias, Nils Wilking, Bengt Jönsson, & Clas Rehnberg. (2007). Health related quality of life in different states of breast cancer. Quality of Life Research. 16(6). 1073–1081. 178 indexed citations
9.
Lidgren, Mathias, A. Gerson Hollander, Ola Weiland, & Bengt Jönsson. (2007). Productivity improvements in hepatitis C treatment: Impact on efficacy, cost, cost-effectiveness and quality of life. Scandinavian Journal of Gastroenterology. 42(7). 867–877. 11 indexed citations
10.
Lidgren, Mathias, et al.. (2007). Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer. Annals of Oncology. 19(3). 487–495. 64 indexed citations
11.
Lidgren, Mathias, Nils Wilking, & Bengt Jönsson. (2007). Cost of breast cancer in Sweden in 2002. The European Journal of Health Economics. 8(1). 5–15. 64 indexed citations
12.
Lundkvist, Jonas, N. Wilking, Stig B. Holmberg, Mathias Lidgren, & Linus Jönsson. (2006). Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden. European Journal of Cancer Supplements. 4(2). 152–152. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026